Lista de obras - Umar Farooq - Dominio Público Uruguay

Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis

artículo científico publicado en 2017

Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis

artículo científico publicado en 2019

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: a NLCS and CIBMTR Analysis.

artículo científico publicado en 2017

Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.

artículo científico publicado en 2018

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

artículo científico publicado en 2017

Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma: Practical Implications for the Community Oncologist

scientific article published on 04 October 2019

Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma

artículo científico publicado en 2010

Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy.

artículo científico publicado en 2017

Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.

artículo científico publicado en 2017

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

scientific article published on 11 March 2019

Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivors

scientific article published on 02 January 2020

Delayed formation of pulmonary artery stump thrombus: a case report and review of the literature.

artículo científico publicado en 2009

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

artículo científico publicado en 2018

Event-free survival at 24 months captures central nervous system relapse of systemic diffuse large B-cell lymphoma in the immunochemotherapy era.

artículo científico publicado en 2017

Frequency, Risk Factors, and Outcomes of Central Nervous System Relapse in Lymphoma Patients Treated with Dose-Adjusted EPOCH plus Rituximab.

artículo científico

Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management

artículo científico publicado en 2016

Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma

artículo científico publicado en 2020

Induced opening of the gastroesophageal junction occurs at a lower gastric pressure in gerd patients and in hiatal hernia subjects than in normal control subjects

artículo científico publicado en 2010

Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

artículo científico publicado en 2019

Late onset imatinib-induced Stevens-Johnson syndrome

artículo científico publicado en 2014

Leptotrichia Bacteremia After Chemotherapy for Hematologic Malignancy

scientific article published on 01 November 2019

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial

artículo científico publicado en 2018

Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma

artículo científico publicado en 2019

Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.

artículo científico publicado en 2014

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

artículo científico

Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma.

artículo científico publicado en 2016

Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma

artículo científico publicado en 2018

Recent progress: hematopoietic cell transplant for diffuse large B-cell lymphoma

artículo científico publicado en 2014

Renal crystal storing histiocytosis in a patient with multiple myeloma

artículo científico publicado en 2009

The association of physical activity before and after lymphoma diagnosis with survival outcomes

scientific article published on 17 October 2018

The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas

artículo científico publicado en 2019

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.

artículo científico publicado en 2018

Lista de obras de Umar Farooq

Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis

Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: a NLCS and CIBMTR Analysis.

Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma: Practical Implications for the Community Oncologist

Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma

Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy.

Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

Compliance with cancer screening and influenza vaccination guidelines in non-Hodgkin lymphoma survivors

Delayed formation of pulmonary artery stump thrombus: a case report and review of the literature.

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

Event-free survival at 24 months captures central nervous system relapse of systemic diffuse large B-cell lymphoma in the immunochemotherapy era.

Frequency, Risk Factors, and Outcomes of Central Nervous System Relapse in Lymphoma Patients Treated with Dose-Adjusted EPOCH plus Rituximab.

Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management

Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma

Induced opening of the gastroesophageal junction occurs at a lower gastric pressure in gerd patients and in hiatal hernia subjects than in normal control subjects

Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

Late onset imatinib-induced Stevens-Johnson syndrome

Leptotrichia Bacteremia After Chemotherapy for Hematologic Malignancy

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial

Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma

Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma.

Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma

Recent progress: hematopoietic cell transplant for diffuse large B-cell lymphoma

Renal crystal storing histiocytosis in a patient with multiple myeloma

The association of physical activity before and after lymphoma diagnosis with survival outcomes

The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.